Kinetics of MDR transport in tumor-initiating cells.

Multidrug resistance (MDR) driven by ABC (ATP binding cassette) membrane transporters is one of the major causes of treatment failure in human malignancy. MDR capacity is thought to be unevenly distributed among tumor cells, with higher capacity residing in tumor-initiating cells (TIC) (though oppos...

Full description

Bibliographic Details
Main Authors: Vasilij Koshkin, Burton B Yang, Sergey N Krylov
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3815210?pdf=render
id doaj-6466096f060b4e83811fdc31eb455fe7
record_format Article
spelling doaj-6466096f060b4e83811fdc31eb455fe72020-11-24T21:49:12ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01811e7922210.1371/journal.pone.0079222Kinetics of MDR transport in tumor-initiating cells.Vasilij KoshkinBurton B YangSergey N KrylovMultidrug resistance (MDR) driven by ABC (ATP binding cassette) membrane transporters is one of the major causes of treatment failure in human malignancy. MDR capacity is thought to be unevenly distributed among tumor cells, with higher capacity residing in tumor-initiating cells (TIC) (though opposite finding are occasionally reported). Functional evidence for enhanced MDR of TICs was previously provided using a "side population" assay. This assay estimates MDR capacity by a single parameter - cell's ability to retain fluorescent MDR substrate, so that cells with high MDR capacity ("side population") demonstrate low substrate retention. In the present work MDR in TICs was investigated in greater detail using a kinetic approach, which monitors MDR efflux from single cells. Analysis of kinetic traces obtained allowed for the estimation of both the velocity (V max) and affinity (K M) of MDR transport in single cells. In this way it was shown that activation of MDR in TICs occurs in two ways: through the increase of V max in one fraction of cells, and through decrease of K M in another fraction. In addition, kinetic data showed that heterogeneity of MDR parameters in TICs significantly exceeds that of bulk cells. Potential consequences of these findings for chemotherapy are discussed.http://europepmc.org/articles/PMC3815210?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Vasilij Koshkin
Burton B Yang
Sergey N Krylov
spellingShingle Vasilij Koshkin
Burton B Yang
Sergey N Krylov
Kinetics of MDR transport in tumor-initiating cells.
PLoS ONE
author_facet Vasilij Koshkin
Burton B Yang
Sergey N Krylov
author_sort Vasilij Koshkin
title Kinetics of MDR transport in tumor-initiating cells.
title_short Kinetics of MDR transport in tumor-initiating cells.
title_full Kinetics of MDR transport in tumor-initiating cells.
title_fullStr Kinetics of MDR transport in tumor-initiating cells.
title_full_unstemmed Kinetics of MDR transport in tumor-initiating cells.
title_sort kinetics of mdr transport in tumor-initiating cells.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description Multidrug resistance (MDR) driven by ABC (ATP binding cassette) membrane transporters is one of the major causes of treatment failure in human malignancy. MDR capacity is thought to be unevenly distributed among tumor cells, with higher capacity residing in tumor-initiating cells (TIC) (though opposite finding are occasionally reported). Functional evidence for enhanced MDR of TICs was previously provided using a "side population" assay. This assay estimates MDR capacity by a single parameter - cell's ability to retain fluorescent MDR substrate, so that cells with high MDR capacity ("side population") demonstrate low substrate retention. In the present work MDR in TICs was investigated in greater detail using a kinetic approach, which monitors MDR efflux from single cells. Analysis of kinetic traces obtained allowed for the estimation of both the velocity (V max) and affinity (K M) of MDR transport in single cells. In this way it was shown that activation of MDR in TICs occurs in two ways: through the increase of V max in one fraction of cells, and through decrease of K M in another fraction. In addition, kinetic data showed that heterogeneity of MDR parameters in TICs significantly exceeds that of bulk cells. Potential consequences of these findings for chemotherapy are discussed.
url http://europepmc.org/articles/PMC3815210?pdf=render
work_keys_str_mv AT vasilijkoshkin kineticsofmdrtransportintumorinitiatingcells
AT burtonbyang kineticsofmdrtransportintumorinitiatingcells
AT sergeynkrylov kineticsofmdrtransportintumorinitiatingcells
_version_ 1725888835088285696